Jennewein Biotechnologie

News and Press Announcements

News and Press Releases

2020

27.05.2020	PR	Jennewein publishes new results on the norovirus-inhibiting effect of complex oligosaccharides: Jennewein Biotechnologie GmbH today announces the publication of the latest… read more
20.05.2020	PR	Supply of Key Ingredient in advanced infant formula by Jennewein is secured: Jennewein Biotechnologie GmbH, a worldwide leading manufacturer of human milk… read more
10.01.2020		Jennewein Biotechnologie GmbH enforces its patents in the field of human milk oligosaccharides against Nestlé in Germany: Jennewein Biotechnologie GmbH filed a patent infringement suit with the… read more
09.01.2020		Publication of a toxicological study: a milestone for Jennewein Biotechnologie for the GRAS approval of the HMO-Mix: Jennewein Biotechnology announces another milestone in the Worldwide approval of… read more

2019

25.11.2019		Jennewein Biotechnologie obtains US-FDA GRAS status on alternative 2’-fucosyllactose fermentation strain.: Nov. 25th. 2019, Jennewein Biotechnologie GmbH, Rheinbreitbach, the leading manufacturer… read more
25.11.2019		Jennewein Biotechnologie sues Glycom for patent infringement in Denmark: Jennewein Biotechnologie develops fermentative processes for manufacturing of human milk… read more
12.09.2019	PR	Administrative Law Judge issues ruling in patent dispute 2′-FL production and beta-galactosidase activity: On September 09, 2019, Administrative Law Judge Cameron Elliot of… read more
05.02.2019		Jennewein Biotechnologie and Yili Group join forces in China for microbiome research and human milk oligosaccharides for the largest baby food market: Jennewein Biotechnologie GmbH, the global leader in the research and… read more

2018

08.10.2018		Jennewein Biotechnologie GmbH acquires Arthus Mineralsprings Bad Hönningen to build a new integrated fermentation and recovery plant for human milk oligosaccharides: Jennewein Biotechnologie GmbH announces that it has acquired the former… read more
19.09.2018	PR	Jennewein Biotechnologie develops new fermentation technology for human milk oligosaccharides and expands its product portfolio: Jennewein Biotechnologie GmbH announces the introduction of a total biosynthesis… read more
22.06.2018		Jennewein Biotechnologie is building a new R&D Center in Bonn: On the 15th June 2018 Jennewein Biotechnologie has signed a… read more
20.06.2018	PR	18th European Congress on Biotechnology: In this year the European Congress on Biotechnology celebrate the… read more
04.05.2018		First clinical trial of a blend of human milk oligosaccharides emulating the human profile of infant formula: Jennewein Biotechnologie GmbH announces its first clinical trial of an… read more
13.04.2018		Jennewein Biotechnologie at the Deutsche Biotechnologietage in Berlin: Since 2010 yearly take place the Deutsche Biotechnologietage. In this… read more
06.04.2018		Jennewein Biotechnologie is finalist for the NutraIngredients Award: This year will take place the 4th edition of the… read more

2017

20.11.2017		EU approval for 2′-fucosyllactose: The Jennewein Biotechnologie GmbH received a response from the European… read more
17.11.2017	PR	Forum for science journalists and scientists: The symposium Wissenswerte is a forum for german science journalists… read more
05.10.2017		Networking for students, postgraduate students and graduates: Since 1999 the Biotechnologische Studenteninitiative e.V. organizes every year the… read more
20.07.2017	PR	Supply Side West, Las Vegas: The show Supply Side West in Las Vegas, who will… read more
20.07.2017	PR	Scientific conference about human milk: From the 16.-21.07.2017 takes part in Lisbon the conference “Origins… read more
20.06.2017		Presence at the fairs in Asia: Human milk oligosaccharides are a future market, especially in the… read more
15.05.2017		Food Asia Pacific Summit: The Food Asia Pacific Summit in Singapore, who will take… read more
15.05.2017		China, a future market: The Health Ingredients China will take place from the 20.-22.06.2017… read more
26.04.2017	PR	50th ESPGHAN Annual Meeting: The 50th annual meeting of the ESPGHAN will take place… read more
25.04.2017	PR	Jennewein Biotechnologie at the Vitafoods Europe: The Vitafoods Europe takes place from the 09.-11.05.2017 in Geneva… read more
17.03.2017		Jennewein Biotechnologie at the Food Vision Asia: The Food Vision Asia will take place from the 25.-27.04.2017… read more
17.03.2017		Jennewein Biotechnologie is part of an EU-campaign: In the context of an image campaign from the European… read more
18.01.2017		Participation at the Food Vision London: The Food Vision London will take place from the 01.-03.03.2017.… read more

2016

27.05.2016		by w4l3XzY3: The Jennewein Biotechnologie GmbH produces rare func- tionals sugars based… read more
25.05.2016	PR	Structural Basis for Norovirus Inhibition by Human Milk Oligosaccharides: Human milk oligosaccharides are a major component of mothers milk,… read more

2015

22.12.2015	PR	US FDA GRAS status for 2′-Fucosyllactose produced by Jennewein Biotechnologie: Jennewein Biotechnologie’s conclusion that its 2’-Fucosyllactose is GRAS for use… read more
02.12.2015	PR	European Investment Bank (EIB) lends EUR 10 million to Jennewein Biotechnologie: Luxembourg, 2 December 2015. The European Investment Bank (EIB) and… read more
30.09.2015		NASPGHAN Annual Meeting 2015: NASPGHAN Annual Meeting 2015 NASPGHAN is the sole professional organization in… read more
21.07.2015		FASEB Conference: Origins and Benefits of Biologically Active Components in Human Milk: Origins and Benefits of Biologically Active Components in Human Milk The… read more
20.04.2015		ESPGHAN Annual Meeting 2015: ESPGHAN Annual Meeting 2015 The scientific programme of the ESPGHAN… read more
15.01.2015		Effects of 2′-Fucosyllactose on hippocampal long-term potentiation and learning capabilities: Publication of Abbott Nutrition on Cognitive Effects of Human Milk… read more

2014

15.12.2014		Toxicology & Safety : A 3-week pre-clinical study of the human milk oligosaccharide 2′-Fucosyllactose in farm piglets: Publication of Toxicology & Safety Study on 2′-Fucosyllactose One of… read more
30.10.2014	PR	Protection against Norovirus by Human-Milk-Oligosaccharides: Federal Ministry of Education and Research supports Development of Norovirus… read more

2013

28.05.2013

Extension of production capacities for human milk oligosaccharides: Jennewein Biotechnologie headquartered in the Technologiezentrum für Oberflächentechnik (TZO) in…
read more

2012

03.12.2012	PR	L-Fucose: Environmentally friendly and cost effective production for active anti-aging ingredient: L-Fucose –Sweet Key to a Youthful Skin Environmentally friendly and… read more
01.11.2012		Distribution partnership between Opalbond and Jennewein Biotechnologie: Jennewein Biotechnologie cooperates with Opelbond in the commercialization of L-Fucose for the use… read more

2011

29.08.2011

PR

Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Oligosaccharides: Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components Jennewein…
read more

2009

07.09.2009	PR	Human Milk Oligosaccharides: Natural Protection against Infectious Diseases: Natural Protection against Infectious Diseases Human-Milk-Oligosaccharides: Biotechnological production of sugar with beneficial… read more
01.08.2009		Distribution partnership between IMPAG and Jennewein Biotechnologie: IMPAG Import GmbH and Jennewein Biotechnology GmbH sign exclusive distribution… read more
15.04.2009		Distribution partnership between Laserson and Jennewein Biotechnologie: Laserson S.A. and Jennewein Biotechnologie GmbH enter in an exclusive… read more